Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
06/2003
06/26/2003WO2003051837A2 Tetrahydrocarbozole derivatives as ligands for g-protein coupled receptors (gpcr)
06/26/2003WO2003051835A2 Methods and compositions for the inhibition of viral release
06/26/2003WO2003051831A2 Protease inhibitors of the coagulation cascade isolated from dysidea sponges
06/26/2003WO2003051797A2 Small-molecule inhibitors of interleukin-2
06/26/2003WO2003020223A3 A cancer treatment system
06/26/2003WO2002016412A3 Binding polypeptides for b lymphocyte stimulator protein (blys)
06/26/2003US20030120052 Human genetic engineering; cancer diagnosis; hybrid nucleic acid
06/26/2003US20030119856 Thiazole compounds useful as inhibitors of protein kinase
06/26/2003US20030119807 Inhibit Procollagen C-proteinase; antiscarring treatment for wounds.
06/26/2003US20030119803 In particular N-epsilon-amino acid substituted L-lysine derivatives possessing aspartyl protease inhibitory properties.
06/26/2003US20030119752 Inhibiting particularly the activity of hepatitis C virus NS3-NS4A protease; peptidomimetics having a bridged bicyclic moiety at the P2 position.
06/26/2003US20030119751 Peptidomimetic; N-aminobutyl-N'-nitroguanidine derivatives
06/26/2003US20030119750 Use of dipeptidyl peptidase IV inhibitors
06/26/2003US20030119748 Use for treatment of inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury.
06/26/2003US20030119745 Treatment of both primary and metastatic solid tumors
06/26/2003US20030119738 N-dipeptidoyl-O-acylhydroxyamines; suicide inhibitors which deactivate the DP I by the reaction with the nucleophilic active site thiol residue.
06/26/2003US20030119720 Oligopeptide treatment of anthrax
06/26/2003US20030119188 Novel compounds
06/26/2003US20030118710 Reductively alkylating aspartame with a 3-(phenyl having specified substituent group(s) on the benzene ring)-2-propene aldehyde and hydrogen in the presence of a catalyst and a base; artificial sweeteners; efficiency
06/26/2003US20030118551 Modified viral surface proteins for binding to extracellular matrix components
06/26/2003CA2470811A1 Protease inhibitors of the coagulation cascade isolated from dysidea sponges
06/26/2003CA2468880A1 Tetrahydrocarbazole derivatives as ligands for g-protein coupled receptors (gpcr)
06/25/2003EP1321471A1 Method for synthesis of perindopril and its pharmaceutically acceptable salts
06/25/2003EP1321151A1 Antiparkinsonism drugs
06/25/2003EP1320540A2 Peptidomimetic protease inhibitors
06/25/2003EP1320538A2 Process for the preparation of 5-phenylpentanoyl-ala-argl-ala- 2-[3-amino-2-oxopyrrolidin-1-yl]propionyl - ala-arg-ala-4-aminophenylacetamide
06/25/2003EP1091932B1 Chiral stationary phases for enantiomers separation and their preparation
06/25/2003EP0678121B1 Methods and reagents for inhibiting furin endoprotease
06/25/2003EP0573603B1 Inhibitors of human neutrophil elastase and human cathepsin g
06/24/2003US6583309 Ureas and compositions thereof for treating cancer, inflammation, or a viral infection
06/24/2003US6583299 α-amino-β-sulfonyl hydroxamic acid compounds
06/24/2003US6583268 Especially those present in inclusion bodies in bacterial hosts, by maintaining alkaline pH in presence of chaotrophic or reducing agents, and decreasing pH gradually over given time to induce renaturation; proteomics
06/24/2003US6582700 Linear antigen supporting units
06/19/2003WO2003050540A2 Flexible method and apparatus for high throughput production and purification of multiple proteins
06/19/2003WO2003050139A2 Prion inhibiting peptides and derivatives thereof
06/19/2003WO2002088172B1 Pentapeptide compounds and uses related thereto
06/19/2003WO2002048172A3 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus
06/19/2003WO2002042462A3 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
06/19/2003WO2002040631A3 Dipeptide seryl-histidine and related oligopeptides cleave dna, protein, and a carboxyl ester
06/19/2003WO2002008244A3 Peptides as ns3-serine protease inhibitors of hepatitis c virus
06/19/2003US20030114642 Peptide
06/19/2003US20030114514 Preventing collagen-based leukocyte adhesion and leukocyte adhesion
06/19/2003US20030114387 Gamma secretase inhibitors
06/19/2003US20030113733 Transcription factors; nuclear localization peptides; human chorionic gonadotropic hormone(hCG); NF-kappaB/Rel proteins
06/19/2003CA2467914A1 Prion inhibiting peptides and derivatives thereof
06/19/2003CA2467736A1 Flexible method and apparatus for high throughput production and purification of multiple proteins
06/18/2003EP1319975A1 Synthesis of peptoid substituted azole compounds
06/18/2003EP1319668A1 Method for synthesis of (2S,3aS,7aS)-1-((S)-alanyl)-octahydro-1H-indole-2-carboxylic acid derivatives and use in the synthesis of perindopril
06/18/2003EP1318829A1 Angiogenic agents and their uses
06/18/2003CN1424322A Trivalent iron porphrin and its derivative-short peptide compound and its synthesis
06/18/2003CN1111520C Matrix metalloprotease inhibitors
06/17/2003US6579972 An antibody having a specific binding affinity to a polypeptide of given amino acid sequence; can use in treating diabetes, skeletal muscle diseases, Alzheimer's disease, or peripheral neuropathies with an agonist or antagonist
06/17/2003US6579890 Matrix metalloprotease inhibitors
06/17/2003CA2046654C Radiolabeled proteins for diagnostic or therapeutic use
06/12/2003WO2003048192A1 Novel peptides and medicinal uses thereof
06/12/2003WO2003048190A2 Acyclovir-peptide analogs
06/12/2003WO2003048127A1 Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formation
06/12/2003WO2003048119A2 Method of producing n-[(2s)-sulfanyl-4-(1,5,5-trimethylhydantoinyl)butanoyl]-l-leucyl-l-tert-leucine n-methylamide and intermediate thereof
06/12/2003WO2003033523A3 Cytotoxic compounds
06/12/2003WO2003016273A3 Peptide arginals and methods for treating disseminated intravascular coagulation
06/12/2003US20030109671 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
06/12/2003US20030109520 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
06/12/2003US20030109517 Azacycloalkanone serine protease inhibitors
06/12/2003US20030109458 Oligopeptides which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using compounds for
06/12/2003US20030109457 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
06/12/2003US20030109456 TRI-, TETRA-, and penta-peptides having antiangiogenic activity
06/12/2003US20030109431 Synthetic tetrapeptide having an amino acide sequence, Glycine- Proline-Arginine-Proline (GPRP) has pro-inflammatory effects on human fibroblastic cells, including synovial cells. An amide analog of GPRP is ineffective in inducing, or
06/12/2003US20030108523 Controlling proliferation of mesothelioma cells; anticancer agent
06/12/2003US20030108520 Insecticides; genetic engineered polypeptide
06/12/2003CA2469134A1 Novel peptide and pharmaceutical use of the same
06/11/2003EP1317475A2 Peptides for use in culture media
06/11/2003EP1317414A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3
06/11/2003EP1317287A2 Polymeric conjugates of antitumor agents
06/11/2003CN1423647A Beta-alanine derivatives and their use as receptor antagonists
06/11/2003CN1423638A Ox (adi) azolyl-hydroxamic acids useful as procollagen C-proteinase inhibitors
06/10/2003US6576766 Signal transduction inhibitors, compositions containing them
06/10/2003US6576653 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors
06/10/2003US6576614 Administering methyl ketones or closed hemiketal derivatives of aspartic acid
06/10/2003US6576613 Title inhibitors of urokinase
06/10/2003US6576454 One or more amino acid residues being replaced by cysteine residues where at least some of cysteine residues are modified by replacing thiol hydrogen in cysteine residue with thiol side chain to form modified enzyme
06/10/2003US6576417 Synthetic antigens for the detection of antibodies to hepatitis C virus
06/10/2003CA2076652C Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase
06/10/2003CA2055670C Retroviral protease inhibiting compounds
06/05/2003WO2003046137A2 Hiv envelope v3-ccr5 binding site immunogen
06/05/2003WO2003045982A1 Antibiotics fki-9739 and process for producing the same
06/05/2003WO2003045981A2 Concentrating aqueous fractions of lisinopril by reverse osmosis
06/05/2003WO2003045974A2 Methods and compositions for derepression of iap-inhibited caspase
06/05/2003WO2003045973A2 Peptides with growth inhibitory action
06/05/2003US20030105327 By-product inhibition of the diketopiperazine derivative by carrying out in aqueous liquid a series of operations under given conditions in the same solvent; making enalapril maleate for example
06/05/2003US20030105292 Continously induced g-protein coupled receptors; membrane binding assays
06/05/2003US20030105286 Comprises pseudo-isocytosine and pseudo-uracil for increasing binding affinity to DNA/RNA strands
06/05/2003US20030105026 For prophylaxis and therapy of infectious diseases such as viral hepatitis B and C, AIDS and herpes
06/05/2003US20030105025 Tri-and tetrapeptides having antiangiogenic activity
06/05/2003US20030105022 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
06/05/2003US20030104991 Didemnin analogs and fragments and methods of making and using them
06/05/2003US20030104985 Anticarcinogenic agent is conjugated with a nucleic acids, for cancer treatment; a kit for detection; chemical intermediates
06/05/2003US20030104589 Tissue adhesive using synthetic crosslinking
06/05/2003US20030104571 Flexible method and apparatus for high throughput production and purification of multiple proteins
06/05/2003US20030104360 Synthetic receptors, libraries and uses thereof
06/05/2003CA2468187A1 Peptides with growth inhibitory action
1 ... 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 ... 307